BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Gemin X Biotechnologies Inc. 

P.O. Box 477
Place du Parc
Montreal,  Quebec    Canada
Phone: 514-281-8989 Fax: 514-281-1065


SEARCH JOBS


Industry
Biotechnology






 Company News
Gemin X Biotechnologies Inc. to Present at the 29th Annual Cowen Healthcare Conference 3/11/2009 9:42:57 AM    More...
Senior Pharmaceutical Executive, Glenn J. Gormley, M.D., Ph.D., to Lead Gemin X Biotechnologies Inc. as President and CEO 6/10/2008 8:33:35 AM    More...
Tripos Discovery Research Ltd. (TRPS), a Subsidiary of Commonwealth Biotechnologies, Inc. (CBTE), Secures a Discovery Milestone Payment from Gemin X Biotechnologies Inc. 8/7/2007 11:17:55 AM    More...
Gemin X Biotechnologies Inc. Announces Publication in Blood of Positive Preclinical Data of Lead Compound in Mantle Cell Lymphoma 5/15/2007 12:05:04 PM    More...
Gemin X Biotechnologies Inc. Initiates a Phase 1 Trial with GMX1777 in Solid Tumors and Lymphomas 5/8/2007 12:37:32 PM    More...
Gemin X Biotechnologies Inc. Presents Positive Preclinical Data of GX15-070 in Infant ALL at American Association for Cancer Research Meeting 4/18/2007 12:59:44 PM    More...
Gemin X Biotechnologies Inc. Announces Publication of Preclinical Data of GX15-070 in Multiple Myeloma in Blood 3/7/2007 12:04:36 PM    More...
Gemin X Biotechnologies Inc. Initiates Phase 1/2 Combination Trials With GX15-070 In Non-Small Cell Lung Cancer And Mantle Cell Lymphoma 1/31/2007 12:03:04 PM    More...
Gemin X Biotechnologies Inc. To Present At The 25th Annual JPMorgan Healthcare Conference 12/21/2006 11:01:45 AM    More...
Gemin X Biotechnologies Inc.'s Pan-Bcl-2 Antagonist GX15-070 Permits Rational Combination With Velcade In Mantle Cell Lymphoma 12/13/2006 10:33:26 AM    More...
123

//-->